Drug Patents owned by Lundbeck Pharms Llc

1. List of Carnexiv drug patents

CARNEXIV's oppositions filed in EPO
CARNEXIV Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9770407 LUNDBECK PHARMS LLC Parenteral carbamazepine formulation
Nov, 2028

(5 years from now)

US9629797 LUNDBECK PHARMS LLC Parenteral carbamazepine formulation
Nov, 2028

(5 years from now)

US8410077 LUNDBECK PHARMS LLC Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

US7635773 LUNDBECK PHARMS LLC Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

US9750822 LUNDBECK PHARMS LLC Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

US9493582 LUNDBECK PHARMS LLC Alkylated cyclodextrin compositions and processes for preparing and using the same
Feb, 2033

(9 years from now)

US11529357 LUNDBECK PHARMS LLC Injectable carbamazepine composition essentially free of 10-bromo-carbamazepine
Jan, 2040

(16 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Oct 7, 2023

Drugs and Companies using CARBAMAZEPINE ingredient

Market Authorisation Date: 07 October, 2016

Treatment: Replacement therapy for oral carbamazepine in adults with partial seizures with complex symptomatology; Replacement therapy for oral carbamazepine in adults with generalized tonic-clonic seizures; Replacement therapy for oral carbamazepine in adults with mixed seizure patterns that include partial seizures with complex symptomatology, generalized tonic-clonic seizures, or other partial or generalized seizures

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

CARNEXIV family patents

25

United States

10

Japan

6

China

5

European Union

4

Russia

4

Mexico

4

Korea, Republic of

4

Canada

4

Australia

2

Spain

2

Brazil

2

New Zealand

2

Hong Kong

2

Israel

1

Portugal

1

EA

1

South Africa

1

Cyprus

1

Slovenia

1

Poland

1

Denmark

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in